Cargando…
Clinical outcomes after treatment of multiple lesions with zotarolimus-eluting versus sirolimus-eluting coronary stents (a SORT OUT III substudy)
BACKGROUND: Data on clinical outcomes among patients treated with the zotarolimus-eluting Endeavor™ stent versus the sirolimus-eluting Cypher™ stent favor the sirolimus-eluting stent. However, a separate comparison of clinical outcome among patients treated for multiple lesions with these stents is...
Autores principales: | Thim, Troels, Maeng, Michael, Lassen, Jens Flensted, Kaltoft, Anne, Jensen, Lisette Okkels, Ravkilde, Jan, Thayssen, Per, Galatius, Søren, Christiansen, Evald Høj, Engstrøm, Thomas, Madsen, Morten, Thuesen, Leif, Tilsted, Hans Henrik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3325867/ https://www.ncbi.nlm.nih.gov/pubmed/22429474 http://dx.doi.org/10.1186/1471-2261-12-18 |
Ejemplares similares
-
Comparison of zotarolimus-eluting and sirolimus-eluting coronary stents: a study from the Western Denmark Heart Registry
por: Maeng, Michael, et al.
Publicado: (2012) -
Clopidogrel discontinuation within the first year after coronary drug-eluting stent implantation: an observational study
por: Thim, Troels, et al.
Publicado: (2014) -
Event detection using population-based health care databases in randomized clinical trials: a novel research tool in interventional cardiology
por: Thuesen, Leif, et al.
Publicado: (2013) -
Impact of diabetes on clinical outcomes after revascularization with the dual therapy CD34 antibody‐covered sirolimus‐eluting Combo stent and the sirolimus‐eluting Orsiro stent
por: Jakobsen, Lars, et al.
Publicado: (2022) -
Impact of acute coronary syndrome on clinical outcomes after revascularization with the dual‐therapy CD34 antibody‐covered sirolimus‐eluting Combo stent and the sirolimus‐eluting Orsiro stent
por: Jakobsen, Lars, et al.
Publicado: (2022)